Please enable JavaScript.
Coggle requires JavaScript to display documents.
HIV / AIDS Theraphy
1 (6, initiating Antiretroviral Theraphy in Treatment…
HIV / AIDS Theraphy
1
-
2, what the Guidelines Address
-
-
-
6, initiating Antiretroviral Theraphy in Treatment -Naive Patients May 2014
-
-
INSTI -Based regimens
DTG + TDF /FTC
EVG /cobi /TDF /FTC Crcl more than 70mL /min (AI)
RAL plus TDF/ FTC (AI)
INSTI integrase strand transfer inhibitor
EVG :
Elvitegravir
DTG = dolutegravir
ABC abacavir
Cobi = cobicistat
RAL = raltegravir
-
- Use of HIV RNA levels to guide Theraphy Decisions
-
8, Testing for drug resistance
-
-
9, other assesment and monitoring studies
-
10, Rating scheme for recommendations
11, recommendations for initiating ART = considerations
12, Potential Benefits of Early Theraphy
13, potential benefits for early theraphy
14, Potential concerns about early theraphy
15, Consider more Rapid initiation of ART
16, Consider Deferral of ART
17, current ARV medications
18, initial ART regimens : DHHS categories
19, Initial Treatment choosing regimens 2015 INSTI based
PI based
20, initial regimens Alternative
NNRTI
PI based
21, initial theraphy : Dual -NRTI pairs
TDF/ FTC
ABC/3TC
22, selecting initial ART Regimen : factors to consider
-
23, ARVs Not Recommended in Initial Treatment
-
-
-